Regarding liver-specific autoantibody responses, autoantibodies to hepatic ASGPR (anti-ASGPR) have been encountered in up to 73% of patients with CH type B (132, 133), but rarely in hepatitis C (<15%) (134). Here, ASGR1 is linked to hepatitis C virus infection.